Following diagnosis of postpartum cerebral angiopathy on postpartum day 10, nimodipine was initiated to treat the vasospasm, and the headache was treated with opioid analgesics and toradol ...

Discover all the brand names or Trade names of generic drug called Nimodipine. This serves as a crucial reference for healthcare professionals, patients, caregivers, and anyone looking to ...

NIMOTOP (nimodipine) is a calcium channel blocker indicated for patients with subarachnoid hemorrhage. It improves neurological outcome by relaxing cerebral smooth muscle vasculature and ...

KOL Event on aneurysmal Subarachnoid Hemorrhage (aSAH) ...

Grace Therapeutics Inc. (NASDAQ:GRCE), a $32.85 million market cap biotechnology company whose stock has gained over 37% in the past six months, has announced successful outcomes from its Phase 3 ...

GRCE READ THE FULL GRCE RESEARCH REPORT Grace Therapeutics, Inc (NASDAQ:GRCE) reported fiscal year (FY) third quarter results following a series of announcements regarding conference participation, ...

The upfront net proceeds from this private placement will also be allocated for general corporate purposes. The injectable formulation of nimodipine is in clinical stages, being developed for IV ...

The injectable formulation of nimodipine is in clinical stages, being developed for IV infusions in patients with aneurysmal subarachnoid haemorrhage (aSAH), a type of stroke caused by the rupture ...

Announced Phase 3 STRIVE-ON Safety Trial Met Primary Endpoint and Provided Clinical Benefit Compared to Orally Administered Nimodipine; New Drug Application (NDA) Submission Anticipated First Half of ...

GTx-104 reduced clinically significant hypotension by 19% versus oral nimodipine (28% vs. 35%) in aSAH patients. 54% of GTx-104 patients maintained 95%+ relative dose intensity versus 8% on oral ...